Effects of two novel bisphosphonates on bone cells in vitro
- 31 December 1994
- journal article
- research article
- Published by Elsevier in Bone and Mineral
- Vol. 26 (2), 95-107
- https://doi.org/10.1016/s0169-6009(08)80055-4
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- PAMIDRONATE TO REDUCE BONE PAIN IN NORMOCALCAEMIC PATIENT WITH DISSEMINATED PROSTATIC CARCINOMAThe Lancet, 1989
- Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APDBone and Mineral, 1989
- Treatment of painful prostatic bone metastases with oral etidronate disodiumUrology, 1988
- TWO-YEAR FOLLOW-UP OF BIPHOSPHONATE (APD) TREATMENT IN STEROID OSTEOPOROSISThe Lancet, 1988
- Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl)thiomethylene bisphosphonate, in the treatment of Paget's disease of boneBone, 1988
- Effects of 1-hydroxyethylidene-1,1 bisphosphonate and (chloro-4 phenyl) thiomethylene bisphosphonic acid (SR 41319) on the mononuclear cell factor-mediated release of neutral proteinases by articular chondrocytes and synovial cellsBiochemical Pharmacology, 1985
- Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeletonThe American Journal of Medicine, 1983
- Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in ratsCalcified Tissue International, 1980
- Effects of Dichloromethylene Diphosphonate on Skeletal Mobilization of Calcium in Multiple MyelomaNew England Journal of Medicine, 1980
- Diphosphonates Inhibit Hydroxyapatite Dissolution in vitro and Bone Resorption in Tissue Culture and in vivoScience, 1969